Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Neurocyte is a Biotechnology Research brand in Singapore. Privately held, at neurocyte-bio.com. Two addresses sit on record, spread over two office countries. It employs 2 people, on the record. One Singapore registration (UEN) is a confirmed match. It is listed alongside two similar brands, mostly in Biotechnology.
UEN202103499M
| NEUROCYTE PTE. LTD. | UEN 202103499M |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Neurocyte is a high-tech company dedicated to developing treatment solutions for brain diseases. Headquartered in Singapore, the company has established R&D centers in Shanghai, China, and Australia, and a clinical trial base in Beijing, China. Neurocyte has an international research team composed of scientists from Australia, Singapore, and China.
One of the company's patented technologies is a novel therapeutic approach that utilizes extracellular vesicles to deliver bioactive substances. Leveraging this technology platform, Neurocyte has partnered with leading experts in the field of brain neuroscience in China to conduct in-depth research on stroke, a major public health issue. As the second leading cause of death in the world and the leading cause of death in China, stroke has long been a huge challenge in the medical community. At present, the exosome products developed by Neurocyte have entered the IIT (early clinical trial) stage, and preliminary results show good efficacy and safety, which marks a significant milestone for the company in addressing this problem.
For more information, please refer to our website.
| Countries | 2 |
|---|---|
| Primary country | SG |
All codes: SG CN
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
One Singapore entity on ACRA: NEUROCYTE PTE. LTD. (UEN 202103499M), high confidence.
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Two addresses on record across 2 countries. Primary: 1 Venture Avenue, Singapore, #01-08, Perennial Business City, Singapore 608521.
None linked to this brand.
1 profile lists Neurocyte as a peer — 30th percentile in Biotechnology Research. It lists four peers of its own. Neocytogen Theraputics lists it back.